Introduction {#sec1}
============

The root of *Panax notoginseng* (Burk.) F.H. Chen, commonly referred to as notoginseng and "*Sanqi*", is a well-known botanic material that has been historically used as both medicinal herb and food. It has been widely used as a tonic and hemostatic agent for the treatment of cardiovascular diseases, inflammation, different body pains, trauma, and internal or external bleeding caused by injury. Substantial studies have demonstrated hemeostatic,^[@ref1]−[@ref3]^ antioxidant,^[@ref4],[@ref5]^ hypolipidemic,^[@ref6]^ hepatoprotective,^[@ref6]−[@ref8]^ renoprotective, and estrogen-like activities of notoginseng.^[@ref6],[@ref9]^ Moreover, chemopreventive and antitumor activities of this herb and its major constituents have been increasingly reported.^[@ref10]−[@ref14]^

Owing to the time-honored benefits for health, notoginseng is also widely used as a distinguished functional food beyond the medicinal application. In China, 47 health foods with notoginseng as a single or major ingredient, including a variety of tablets, capsule, and medicinal liquors, have been approved by the China Food and Drug Administration for manufacturing. These health foods are claimed to benefit people with low immunity and hyperlipidemia because of their health functions such as liver protection, immunomodulation, blood lipid regulation, antifatigue effect, and antihypoxia activity. In addition, notoginseng is also widely consumed in the form of tea, powder, and raw materials of Chinese soup in China and other Asian countries. In the United States, a variety of notoginseng products are available as dietary supplements in the health food market.^[@ref5],[@ref15]^

Although both rhizome and root (Notoginseng Radix et Rhizoma) are officially described as notoginseng in "Chinese Pharmacopoeia" since 1985, individual parts of the whole root, that is, rhizome, main root, branch root, and fibrous root, were separately used, and their market values are greatly different. Rhizome, commonly known as "*Jiankou*", is usually used for the manufacturing of ginsenosides and related preparations.^[@ref16]^ The main root is generally utilized in Chinese medical clinics and traditional Chinese proprietary medicines, whereas branch root (known as "*Jintiao*") and fibrous root are often ground to yield powder as health food. The market prices of the different parts rank in the order main root \> rhizome and branch root \> fibrous root.

Due to the different utilizations of individual parts of notoginseng, chemical differences among them are of great significance for both authentication and medicinal usage of different parts of this herb. Although numerous studies have been carried out to assess the chemical differences among notoginseng, American ginseng (the root of *Panax quinquefolius* L.), and Asian ginseng (the root of *Panax ginseng* C.A. Mey.),^[@ref17],[@ref18]^ only limited studies have been performed to assess the chemical characteristics of individual parts of notoginseng.^[@ref19]−[@ref24]^ Consequently, the following limitations still existed: (1) More than 80 dammarane-type saponins with various bioactivities have been isolated from notoginseng and steamed notoginseng,^[@ref7],[@ref25]−[@ref33]^ but only major ginsenosides, that is, notoginsenoside R~1~, ginsenosides Rg~1~, Re, Rb~1~, and Rd, have been examined in most of the previous studies.^[@ref21],[@ref23],[@ref34]−[@ref37]^ Several recent studies quantitatively determined both high- and low-abundance ginsenosides,^[@ref24],[@ref38]^ but the total number of quantified saponins is still quite limited. (2) Metabolite profiling by using UPLC-ESI-MS has been applied for evaluating the chemical characteristics of different parts of *P. notoginseng*, that is, flower, leaf, seed, rhizome, and main root,^[@ref19],[@ref39],[@ref40]^ or raw notoginseng and steamed notoginseng.^[@ref40]^ However, this approach is still not well applied for the examination of different underground parts of *P. notoginseng*. Especially, comparison among the four parts of notoginseng by using a metabolomics approach is absent. (3) Comparison was often made among the different parts sampled from roots of diverse origin (e.g, roots collected from different regions or collected at different seasons). However, the different origin itself might introduce significant variation in the content of chemical constituents. As such, the "real" variation resulting from biosynthesis in different portions of the root might be compromised by the origin-derived variation.

Therefore, we herein conducted a quantitative comparison on the different parts derived from the whole root of *P. notoginseng* collected from the major production region of notoginseng, Wenshan city, Yunnan province. Eight dammarane-type saponins were quantitatively compared by using the validated UPLC-Q-TOF MS method. Commercial samples of individual parts of notoginseng were also analyzed to verify the chemical difference. A nontargeted metabolomics approach was subsequently applied for discrimination of different parts of the root. This combinative comparison approach facilitated an overall evaluation of chemical difference among these closely related samples.

Materials and Methods {#sec2}
=====================

Plant Materials {#sec2.1}
---------------

Twelve batches of the whole root of *P. notoginseng* (3 years) were collected from the wholesale markets of Wenshan, Yunnan province, China, in December 2008. For each batch of the root, three to five of the whole roots were divided into rhizome, main root, branch root, and fibrous root. The obtained individual parts were then mixed to yield the representative portion of each batch. The yield of each part from the whole root was measured to be 15% (rhizome), 66% (main root), 18% branch root, and 2% (fibrous root) on average. Commercial samples of individual parts of notoginseng were also collected from the markets of Wenshan during 2006--2008, including four batches of rhizome; main roots with growing years of 3 years (four batches), 4 years (two batches), and 5 years (two batches); four batches of main root without growing year information; four batches of branch root; and six batches of fibrous root.

Chemicals {#sec2.2}
---------

Notoginsenoside R~1~ and ginsenoside Rg~1~ (purity \> 98%) were purchased from Kunming Zhongzheng Biotech Co., Ltd. (Kunming, China); ginsenosides Re, Rb~1~, Rb~2~, Rb~3~, Rc, and Rd (each purity \> 98%) were purchased from Chengdu Scholar Biotech Co., Ltd. (Chengdu, China). HPLC grade methanol and acetonitrile were purchased from Anaqua Chemicals Supply Inc., Ltd. (Houston, TA, USA), and distilled water was purified by a Milli-Q system (Millipore).

Preparation of Standard and Sample Solution {#sec2.3}
-------------------------------------------

Stock solutions of notoginsenoside R~1~ and ginsenosides Rg~1~, Re, Rb~1~, Rb~2~ and Rd in 70% methanol were diluted to a series of working solutions (0.125, 0.625, 1.25, 2.5, 5, and 10 μg/mL), whereas those of ginsenosides Rb~3~ and Rc were diluted to yield working solutions of 0.05, 0.25, 0.5, 1, 2, and 4 μg/mL.

Sample solutions were prepared following the procedures developed in our previous studies.^[@ref41],[@ref42]^ Briefly, 200 mg of powdered samples of each representative part was accurately weighed into a PTFE-stopped tube and sonicated with 10 mL of 70% methanol for 1 h. The mixture was centrifuged, and the supernatant was collected and then diluted by 200- and 4-fold for the quantitation of major ginsenosides (R~1~, Rg~1~, Re, Rb~1~, Rd, and Rb~2~) and minor ginsenosides (Rb~3~ and Rc), respectively. All samples were filtered through a 0.2 μm filter before analysis.

LC-MS Analysis {#sec2.4}
--------------

LC-MS was performed using a Waters Acquity UPLC system (Waters, Milford, MA, USA) coupled to a Bruker MicroTOF mass spectrometer with an ESI source (Bruker, Bremen, Germany). All of the operation, acquisition, and data analysis were operated by Hystar software (Bruker). MS/MS experiments were carried out on an Agilent 1290 infinity UHPLC system (Santa, Clara, CA, USA) coupled with an Agilent 6550 QTOF.

Chromatographic separation was performed on an Acquity UPLC BEH C~18~ column (2.1 mm × 100 mm, 1.7 μm). The mobile phase consisted of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B), with a flow rate of 0.35 mL/min. The following gradient was used: 0--23 min, 10--40% B; 23--27 min, 40--85% B; 27--29 min, 85--100% B; 29--32 min, 100% B; 32--36 min, 10% B. The column was maintained at 40 °C, and the injection volume of each sample was 1 μL.

The mass spectrometer was operated in the negative mode with a scanning range of *m*/*z* 100--3000. The optimized mass conditions were as follows: drying gas (N~2~) flow rate, 8 L/min; drying gas temperature, 180 °C; capillary voltage, 4500 V; nebulizing gas (N~2~) pressure, 2.5 bar; end plate offset, −500 V. The following ions were extracted for the quantitative analysis of different compounds: *m*/*z* 977.5 (\[M + HCOO\]^−^, notoginsenoside R~1~), *m*/*z* 845.5 (\[M + HCOO\]^−^, ginsenoside Rg~1~), *m*/*z* 991.5 (\[M + HCOO\]^−^, ginsenosides Re and Rd), *m*/*z* 1153.5 (\[M + HCOO\]^−^, ginsenoside Rb~1~), *m*/*z* 1123.5 (\[M + HCOO\]^−^, ginsenosides Rb~2~, Rb~3~, and Rc).

Method Validation for Quantitation {#sec2.5}
----------------------------------

The calibration curve (*y* = *a* + *bx*) for each ginsenoside was constructed by plotting the peak area against concentration, and the linearity was verified by correlation coefficients (*r*^2^). The lower limit of detection (LOD) and lower limit of quantification (LOQ) were determined on the basis of response at signal-to-noise ratios (S/N) of 3 and 10, respectively. The precision was determined by intra- and interday variations. The intraday precision was performed by six replicate analyses of a mixed standard solution within a day, and the interday precision was carried out by analyzing the same mixed standard solution on five consecutive days. The repeatability was evaluated by carrying out six replicate analyses of the same sample. The recovery test was performed by spiking a sample with the mixed standards, and the recovery rate was calculated by using the following formula: recovery rate (%) = (observed amount -- original amount)/spiked amount × 100%. Variations were expressed as relative standard deviations (RSD%).

Multivariate Analysis {#sec2.6}
---------------------

The UPLC-Q-TOF MS data of different parts of notoginseng were first exported as cdf format. The peak finding, alignment, and filtering of raw data were preprocessed by MassLynx V4.1 (Waters, Milford, MA, USA). The parameters were set as the following conditions: retention time of 2--27 min, mass range of 100--1500 Da, mass tolerance of 0.05 Da. The resulting three-dimensional matrix using retention time, mass to charge ratio, and intensities of all detected peaks were tabulated and exported for subsequent analysis. Principal component analysis (PCA), partial least squares discriminate analysis (PLS-DA), and orthogonal partial least squares discriminate analysis (OPLS-DA) were performed by using SIMCA 13.0 software (Umetrics, Umea, Sweden). Components that played important roles in differentiation were picked out according to the variable importance in the projection (VIP) value.

Results and Discussion {#sec3}
======================

Method Validation for Quantitation {#sec3.1}
----------------------------------

All calibration curves showed good linearity (*r*^2^ \> 0.999). The LOD ranged from 0.0038 to 0.0146 μg/mL, and the LOQ ranged from 0.0171 to 0.0541 μg/mL. The calibration curves, correlation coefficients, LOD, and LOQ of each compound are given in Table [1](#tbl1){ref-type="other"}. The UPLC-Q-TOF MS method showed good precision for the quantitation of the eight saponins with intra- and interday variations of 1.28--3.00 and 1.22--3.44% and repeatability variations of 1.08--3.84%. The overall recoveries ranged from 97.70 to 103.03%, with variations of 1.60--3.46% (Table [1](#tbl1){ref-type="other"}). These results demonstrated that the established UPLC-Q-TOF MS method was sensitive, accurate (with recovery accuracy within the criteria of 95--105%), and precise (with precision of \<5%) and thereby appropriate for the quantitative analyses of notoginsenoside R~1~ and ginsenosides Rg~1~, Re, Rb~1~, Rb~2~, Rb~3~, Rc, and Rd in different parts of notoginseng.

###### Validation Data of UPLC-MS Quantitative Method for Eight Saponins

                                                           precision (RSD%) (*n* = 6)                                                                        
  ------- --------------------------- ----------- -------- ---------------------------- ------ ------ ---------------------------------------------- ------- -------
  R~1~    *y* = 132995*x* + 4969.8    0.125--10   0.9998   1.99                         1.25   2.25   98.66 (1.81)[a](#t1fn1){ref-type="table-fn"}   0.005   0.021
  Rg~1~   *y* = 125416*x* -- 6776.7   0.125--10   0.9998   1.28                         1.99   1.08   99.10 (2.90)                                   0.004   0.024
  Re      *y* = 148540*x* + 15054     0.125--10   0.9995   2.67                         2.18   2.11   103.03 (2.22)                                  0.005   0.017
  Rb~1~   *y* = 64969*x* -- 4164.7    0.125--10   0.9997   2.31                         2.60   1.72   99.65 (3.29)                                   0.015   0.054
  Rb~2~   *y* = 116356*x* -- 5883     0.125--10   0.9997   2.87                         1.68   3.84   99.06 (3.43)                                   0.011   0.029
  Rb~3~   *y* = 134365*x* -- 851      0.05--4     0.9999   3.00                         3.44   1.61   97.7 (1.26)                                    0.008   0.025
  Rc      *y* = 122449*x* -- 500.33   0.05--4     0.9999   2.18                         2.21   2.79   99.62 (2.70)                                   0.008   0.026
  Rd      *y* = 152720*x* -- 6790.6   0.125--10   0.9999   2.41                         1.22   2.97   101.65 (1.60)                                  0.006   0.021

The values in the parentheses are the RSDs of six replicated determinations of recovery rate.

Quantitative Comparison of Different Parts of Notoginseng {#sec3.2}
---------------------------------------------------------

The contents of chemical constituents are always influenced by various factors such as the place of origin, the growing year, and the harvesting season. To evaluate the variation of ginsenosides inherently associated with the different parts of the root, we specially collected the whole root for the comparative study. The qualitative results revealed quite similar content distribution of eight dammarane-type saponins in different parts of the root (Figure [1](#fig1){ref-type="fig"}). As can be seen in Table [1](#tbl1){ref-type="other"}, in all parts of the root, ginsenosides Rb~1~ and Rg~1~ were shown to be the most abundant ginsenosides, both accounting for \>20% of the total saponins (Table [2](#tbl2){ref-type="other"}). Notoginsenoside R~1~ was less abundant than Rg~1~ and Rb~1~, but with great variation among individual samples in both absolute content and relative composition of the total amount of saponins. Content of ginsenosides Re and Rd also varied greatly among individual samples, but their percentage in the total amount of saponins remained at about 1--10% in most portion samples of the root, whereas ginsenosides Rb~2~, Rc, and Rb~3~ were minor constituents in all parts of the root ([Supporting Information](#notes-1){ref-type="notes"}, Table S1). In commercial samples, similar patterns were observed for all individual parts of notoginseng (Figure [3](#fig3){ref-type="fig"}).

![Total ion chromatogram (TIC) of rhizome (A), main root, (B) branch root (C), and fibrous root (D) of *Panax notoginseng*.](jf-2014-02214x_0001){#fig1}

###### Potential Marker Compounds Responsible for Differentiation of Rhizome, Main Root, Branch Root, and Fibrous Root of *Panax notoginseng*

  no.   identificaton                                                                    VIP     *t*~R~ (min)   calcd mass   measured mass   error (ppm)   ion species              molecular formula   fragment (*m*/*z*)
  ----- -------------------------------------------------------------------------------- ------- -------------- ------------ --------------- ------------- ------------------------ ------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1     ginsenoside Rb~1~                                                                22.67   18.26          1153.6011    1153.6003       --0.7         \[M + HCOO\]^−^          C~54~H~92~O~23~     1107.5952 \[M -- H\]^−^, 945.5421 \[M -- H -- Glc\]^−^, 783.4901 \[M -- H -- 2Glc\]^−^, 621.4370 \[M -- H -- 3Glc\]^−^, 459.3851 \[M -- H -- 4Glc\]^−^
  2     malonyl-ginsenoside Rb~1~                                                        17.71   18.64          1193.5961    1193.6004       3.6           \[M -- H\]^−^            C~57~H~94~O~26~     1149.6009 \[M -- H -- CO~2~\] ^--^, 1107.5986 \[M -- H -- malonyl\]^−^, 1089.5857 \[M -- H -- malonyl -- H~2~O\]^−^, 945.5532 \[M -- H -- malonyl -- Glc\]^−^, 927.5230 \[M -- H -- malonyl -- Glc -- H~2~O\]^−^, 825.4972 \[M -- H -- CO~2~ -- 2Glc\] ^--^, 783.4871 \[M -- H -- malonyl -- 2Glc\]^−^, 621.4402 \[M -- H -- malonyl -- 3Glc\]^−^
  3     ginsenoside Rd                                                                   16.77   21.20          991.5483     991.5482        --0.1         \[M + HCOO\]^−^          C~48~H~82~O~18~     945.5423 \[M -- H\]^−^, 783.4901 \[M -- H -- Glc\]^−^, 765.4788 \[M -- H -- Glc -- H~2~O\]^−^, 621.4374 \[M -- H -- 2Glc\]^−^, 603.4284 \[M -- H -- 2Glc -- H~2~O\]^−^, 459.3844\[M-H-3Glc\]^−^
  4     ginsenoside Rg~1~                                                                14.03   11.22          845.4904     845.4913        1             \[M + HCOO\]^−^          C~42~H~72~O~14~     799.4825 \[M -- H\]^−^, 637.4316 \[M -- H -- Glc\]^−^, 619.4183 \[M -- H -- Glc-H~2~O\]^−^, 475.3796 \[M -- H -- 2Glc\]^−^, 457.3689 \[M -- H -- 2Glc -- H~2~O\]^−^
  5     notoginsenoside K                                                                11.94   22.36          991.5483     991.5509        2.6           \[M + HCOO\]^−^          C~48~H~82~O~18~     945.5419 \[M -- H\]^−^, 783.4870 \[M -- H -- Glc\]^−^, 765.4788 \[M -- H -- Glc -- H~2~O\]^−^, 621.4356 \[M -- H -- 2Glc\]^−^, 603.4214 \[M -- H -- 2Glc -- H~2~O\]^−^, 459.3840 \[M -- H -- 3Glc\]^−^
  6     notoginsenoside R~1~                                                             11.89   10.34          977.5327     977.5291        --3.7         \[M + HCOO\]^−^          C~47~H~80~O~18~     931.5278 \[M -- H\]^−^, 799.4845 \[M -- H -- Xyl\]^−^, 781.4743 \[M -- H -- Xyl -- H~2~O\]^−^, 769.4744 \[M -- H -- Glc\]^−^, 751.4629 \[M -- H -- Glc -- H~2~O\]^−^, 637.4324 \[M -- H -- Xyl -- Glc\]^−^, 619.4220 \[M -- H -- Xyl -- Glc -- H~2~O\]^−^, 475.3797 \[M -- H -- Xyl -- 2Glc\]^−^
  7     notoginsenoside Rw~1~                                                            11.69   17.17          947.5221     947.5199        --2.3         \[M + HCOO\]^−^          C~46~H~78~O~17~     901.5160 \[M -- H\]^−^, 769.4766 \[M -- H -- Xyl\]^−^, 637.4311 \[M -- H -- 2Xyl\]^−^, 475.3794 \[M -- H -- 2Xyl -- Glc\]^−^
  8     ginsenoside Rb~2~                                                                9.43    19.60          1123.5906    1123.5945       3.4           \[M + HCOO\]^−^          C~53~H~90~O~22~     1077.5861 \[M -- H\]^−^, 945.5278 \[M -- H -- Xyl\]^−^, 915.5379 \[M -- H -- Glc\]^−^, 783.4869 \[M -- H -- Xyl -- Glc\]^−^, 765.4677 \[M -- H -- Xyl -- Glc -- H~2~O\]^−^, 621.4399 \[M -- H -- Xyl -- 2Glc\]^−^, 603.4351 \[M -- H -- Xyl -- 2Glc -- -H~2~O\]^−^, 459.3876 \[M -- H -- Xyl -- 3Glc\]^−^
  9     malonyl-ginsenoside Rd                                                           9.07    21.91          1031.5432    1031.5465       3.2           \[M -- H\]^−^            C~51~H~84~O~21~     987.5508 \[M -- H -- CO~2~\]^−^, 945.5399 \[M − H − malonyl\]^−^, 927.5307 \[M -- H -- malonyl -- H~2~O\]^−^, 783.5049 \[M -- H -- malonyl -- Glc\]^−^
  10    ginsenoside Re                                                                   8.65    11.30          991.5483     991.5509        2.6           \[M + HCOO\]^−^          C~48~H~82~O~18~     945.5430 \[M -- H\]^−^, 799.4834 \[M -- H -- Rha\]^−^, 783.4900 \[M -- H -- Glc\]^−^, 765.4793 \[M -- H -- Glc -- H~2~O\]^−^, 637.4323 \[M -- H -- Rha -- Glc\]^−^, 619.4214 \[M -- H -- Rha -- Glc -- H~2~O\]^−^, 475.3792 \[M -- H -- Rha -- 2Glc\]^−^
  11    ginsenoside Rg~3~                                                                8.47    24.84          829.4955     829.4989        4.1           \[M + HCOO\]^−^          C~42~H~72~O~13~     783.4896 \[M -- H\]^−^, 621.4426 \[M -- H -- Glc\]^−^, 603.4216 \[M -- H -- Glc -- H~2~O\]^−^, 459.3803 \[M -- H -- 2Glc\]^−^
  12    notoginsenoside R~4~/ ginsenoside Ra~3~                                          6.04    17.45          1239.6374    1239.6379       --2.46        \[M -- H\]^−^            C~59~H~100~O~27~    1107.5934 \[M -- H -- Xyl\]^−^, 1089.5813 \[M -- H -- Xyl -- H~2~O\]^−^, 1077.5904 \[M -- H -- Glc\]^−^, 945.5438 \[M -- H -- Xyl -- Glc\]^−^, 915.5320 \[M -- H -- 2Glc\]^−^, 783.4890 \[M -- H -- Xyl -- 2Glc\]^−^, 765.4824 \[M -- H -- Xyl -- 2Glc -- -H~2~O\]^−^, 621.4360 \[M -- H -- Xyl -- 3Glc\]^−^
  13    notoginsenoside R~2~/ ginsenoside F~5~/ ginsenoside La                           5.88    18.09          815.4798     815.4792        0.95          \[M + HCOO\]^−^          C~41~H~70~O~13~     769.4728 \[M -- H\]^−^, 637.4318 \[M -- H -- Xyl\]^−^, 475.3783 \[M -- H -- Xyl -- Glc\]^−^
  14    notoginsenoside Fa/notoginsenoside R~4~/ ginsenoside Ra~3~                       5.59    16.77          1239.6374    1239.6399       1.19          \[M -- H\]^−^            C~59~H~100~O~27~    1107.6014 \[M -- H -- Xyl\]^−^, 1077.5904 \[M -- H -- Glc\]^−^, 945.5473 \[M -- H -- Xyl -- Glc\]^−^, 927.5299 \[M -- H -- Xyl -- Glc -- H~2~O\]^−^, 783.489 \[M -- H -- Xyl -- 2Glc\]^−^, 765.4788 \[M -- H -- Xyl -- 2Glc -- -H~2~O\]^−^
  15    floralginsenoside E/floralginsenoside F                                          5.51    4.92           861.4853     861.4848        0.59          \[M + HCOO\]^−^          C~42~H~72~O~15~     815.4779 \[M -- H\]^−^, 653.4239 \[M -- H -- Glc\]^−^, 635.4188 \[M -- H -- Glc -- H~2~O\]^−^, 491.3739 \[M -- H -- 2Glc\]^−^
  16    ginsenoside Rc                                                                   5.36    18.97          1077.5852    1077.5851       0.68          \[M -- H\]^−^            C~53~H~90~O~22~     945.5278 \[M -- H -- Xyl\]^−^, 915.5383 \[M -- H -- Glc\]^−^, 783.4916 \[M -- H -- Xyl -- Glc\]^−^, 765.4830 \[M -- H -- Xyl -- Glc -- H~2~O\]^−^, 621.4399 \[M -- H -- Xyl -- 2Glc\]^−^, 603.4351 \[M -- H -- Xyl -- 2Glc-H~2~O\]^−^, 459.3876 \[M -- H -- Xyl -- 3Glc\]^−^
  17    notoginsenoside I                                                                4.76    17.58          568.2989     568.2970        --3.3         \[M -- H + HCOO\]^2--^   C~54~H~92~O~22~     1091.5981 \[M -- H\]^−^, 929.5497 \[M -- H -- Glc\]^−^, 767.4939 \[M -- H -- 2Glc\]^−^, 605.4420 \[M -- 2H -- 3Glc\]^−^
  18    10-hydroxy-4,6-decadiynoic acid                                                  4.74    3.56           503.1770     503.1764        1.19          \[M -- H\]^−^            C~22~H~32~O~13~     503.1769 \[M -- H\]^−^, 341.1234 \[M -- H -- Glc\]^−^
  19    ginsenoside Rf/ginsenoside la/ginsenoside lb/notoginsenoside U                   4.62    16.60          845.4904     845.4898        0.91          \[M + HCOO\]^−^          C~42~H~72~O~14~     799.4825 \[M -- H\]^−^, 637.4316 \[M -- H -- Glc\]^−^, 475.3796 \[M -- H -- 2Glc\]^−^
  20    notoginsenoside R~2~/ ginsenoside F~5~/ ginsenoside La                           3.98    16.98          815.4798     815.482         2.7           \[M + HCOO\]^−^          C~41~H~70~O~13~     769.4728 \[M -- H\]^−^, 637.4318 \[M -- H -- Xyl\]^−^, 619.4202 \[M -- H -- Xyl -- H~2~O\]^−^, 475.3783 \[M -- H -- Xyl -- Glc\]^−^, 457.643 \[M -- H -- Xyl -- Glc -- H~2~O\]^−^
  21    notoginsenoside Fa/notoginsenoside R~4~/ ginsenoside Ra~3~                       3.69    18.24          1239.6374    1239.6375       0.84          \[M -- H\]^−^            C~59~H~100~O~27~    1107.5901 \[M -- H -- Xyl\]^−^, 1089.5897 \[M -- H -- Xyl -- H~2~O\]^−^, 945.5394 \[M -- H -- Xyl -- Glc\]^−^, 783.4790 \[M -- H -- Xyl -- 2Glc\]^−^, 765.4824 \[M -- H -- Xyl -- 2Glc -- -H~2~O\]^−^, 621.4331 \[M -- H -- Xyl -- 3Glc\]^−^, 459 \[M -- H -- Xyl -- 4Glc\]^−^
  22    ginsenoside Ra~1~/ ginsenoside Ra~2~/ notoginsenoside Fc/notoginsenoside FP~2~   3.32    19.02          1209.6274    1209.629        0.69          \[M -- H\]^−^            C~58~H~98~O~26~     1077.5815 \[M -- H -- Xyl\]^−^, 945.5171 \[M -- H -- Xyl -- Ara\]^−^, 915.5203 \[M -- H -- Xyl -- Glc\]^−^, 783.4702 \[M -- H -- Xyl -- Ara -- Glc\]^−^, 621.4456 \[M -- H -- Xyl -- Ara -- 2Glc\]^−^, 459.4373 \[M -- H -- Xyl -- Ara -- 3Glc\]^−^
  23    notoginsenoside A/koryoginsenoside Rg~2~                                         3.22    12.88          584.2938     584.2926        --2.2         \[M -- H + HCOO\]^2--^   C~54~H~92~O~24~     1123.5821 \[M -- H\]^−^, 961.5508 \[M -- H -- Glc\]^−^, 799.4908 \[M -- H -- 2Glc\]^−^, 561.2922 \[M -- 2H\]^2--^
  24    ginsenoside Rg~2~                                                                2.61    17.86          829.4955     829.4969        1.7           \[M + HCOO\]^−^          C~42~H~72~O~13~     783.4896 \[M -- H\]^−^, 637.4303 \[M -- H -- Rha\]^−^, 619.4279 \[M -- H -- Rha -- H~2~O\]^−^, 475.3790 \[M -- H -- Rha -- Glc\]^−^, 457.3690 \[M -- H -- Rha -- Glc -- H~2~O\]^−^
  25    ginsenoside Rh~1~                                                                2.47    17.85          683.4376     683.4345        4.5           \[M + HCOO\]^−^          C~36~H~62~O~9~      637.4318 \[M -- H\]^−^, 475.3770 \[M -- H -- Glc\]^−^
  26    panaxoside C                                                                     2.30    20.73          975.5534     975.5544        0.81          \[M + HCOO\]^−^          C~48~H~82~O~17~     929.5470 \[M -- H\]^−^, 767.4978 \[M -- H -- Glc\]^−^
  27    20-glucoginsenoside Rf/floralginsenoside La/floralginsenoside Lb                 2.28    23.66          961.5378     961.5380        0.03          \[M -- H\]^−^            C~48~H~82~O~19~     799.4854 \[M -- H -- Glc\]^−^, 781.4751 \[M -- H -- Glc -- H~2~O\]^−^, 637.4334 \[M -- H -- 2Glc\]^−^, 619.4242 \[M -- H -- 2Glc -- H~2~O\]^−^, 475.3794 \[M -- H -- 3Glc\]^−^
  28    6,20-di-*O*-β-[d]{.smallcaps}-glucopyranoside                                    2.28    11.23          843.4748     843.4740        2.25          \[M + HCOO\]^−^          C~42~H~70~O~14~     797.4710 \[M -- H\]^−^, 635.4210 \[M -- H -- Glc\]^−^
  29    notoginsenoside J                                                                2.17    2.85           879.4959     897.4953        1.07          \[M + HCOO\]^−^          C~42~H~74~O~16~     833.5020 \[M -- H\]^−^, 671.4385 \[M -- H -- Glc\]^−^
  30    notoginsenoside D/notoginsenoside T                                              2.06    18.27          1371.6802    1371.6806       1.05          \[M -- H\]^−^            C~64~H~108~O~31~    685.3421 \[M -- 2H\]^2--^, 619.3171 \[M -- 2H -- Xyl\]^2--^, 553.7970 \[M -- 2H -- 2Xyl\]^2--^
  31    vinaginsenoside R~20~/ginsenoside III                                            1.89    13.28          1005.5276    1005.5266       1.45          \[M + HCOO\]^−^          C~48~H~80~O~19~     959.5205 \[M -- H\]^−^, 797.4775 \[M -- H -- Glc\]^−^, 635.4040 \[M -- H -- 2Glc\]^−^, 473.3665 \[M -- H -- 3Glc\]^−^
  32    notoginsenoside H                                                                1.87    4.55           993.5276     993.5285        0.93          \[M -- H\]^−^            C~48~H~82~O~21~     947.5253 \[M -- H\]^−^, 785.4690 \[M -- H -- Glc\]^−^, 767.4594 \[M -- H -- Glc -- H~2~O\]^−^, 653.4277 \[M -- H -- Xyl -- Glc\]^−^, 635.4162 \[M -- H -- Xyl -- Glc -- H~2~O\]^−^, 491.3763 \[M -- H -- Xyl -- 2Glc\]^−^

Among different parts of the root, the content of each saponin was always the highest in rhizome, followed by main root and branch root, and then fibrous root. This observation was consistent with previous studies.^[@ref24],[@ref39],[@ref43]^ Individually, except for notoginsenoside R~1~, contents of all ginsenosides in rhizome were significantly higher than those in main root (Figure [2](#fig2){ref-type="fig"}), among which Rb~2~ was the most important ginsenoside as featured by up to 8-fold content in rhizome of that in main root (Figure [2](#fig2){ref-type="fig"}). The higher content of each saponin in rhizome accumulatively led to the significantly higher content of subtotal PPD-type and PPT-type ginsenosides, as well as the content of total saponins than that in main root (Figure [2](#fig2){ref-type="fig"}). On average, the content of total ginsenosides in rhizome is about 20--60% higher than that in main root and about 50--90% higher than that in branch root. The higher saponin content, together with the considerable biomass of the rhizome (about 15% of the whole root), supported the utilization of rhizome as the raw material for manufacturing ginsenoside-based products.

![Contents of eight dammarane-type saponins and total saponins in rhizome, main root, branch root, and fibrous root of *P. notoginseng*. Each bar represents the mean ± SD (*n* = 12). (∗) *p* \< 0.05, one-way ANOVA (compared with main root).](jf-2014-02214x_0002){#fig2}

The contents of all eight ginsenosides in branch root appear to be lower than that in main root, but statistical significance for such difference was not observed (*p* value \> 0.05). Moreover, in PLS-DA scores plot (Figure [4](#fig4){ref-type="fig"}A), branch root is almost superimposed with main root but separated from rhizome and fibrous root. In OPLS-DA scores plot, branch root is separated from main root but still very close to the main root in the space. These results indicated an overall similar chemical profile of branch root with main root, therefore supporting the equivalent usage of branch root and main root as indicated in "Chinese Pharmacopeia".

In commercial unassorted samples, the content of individual saponins in the rank order of rhizome \> main root ≥ branch root \> fibrous root was also observed, demonstrating this is an overall pattern of saponin distribution in different parts of notoginseng. Consistent with that revealed in whole root-derived samples, significant differences in the content of ginsenosides Rg~1~, Rb~1~, Rd, Rc, and Rb~2~ between rhizome and main root were observed, despite the great intragroup variation (Figure [3](#fig3){ref-type="fig"}). In addition, significant difference in the contents of R~1~, Rg~1~, Re, and Rb~1~ between main root and fibrous root were observed. Most notable is the significantly different contents of Rb~2~ in rhizome and other parts (Figure [3](#fig3){ref-type="fig"}). It has been found that the content of Rb~2~ in rhizome was \>0.5 mg/g in all samples, whereas the contents in other parts were all \<0.3 mg/g and mostly \<0.2 mg/g. This evidence facilitated 0.5 mg/g of Rb~2~ as a threshold value for the discrimination of rhizome and other parts of notoginseng.

![Contents of eight dammarane-type saponins in the commercial sample of rhizome (*n* = 4), main root (*n* = 12), branch root (*n* = 4), and fibrous root (*n* = 6) of *P. notoginseng*. (∗) *p* \< 0.05, (∗∗) *p* \< 0.01, (∗∗∗) *p* \< 0.001, one-way ANOVA (compared with main root).](jf-2014-02214x_0003){#fig3}

Multivariate Analysis of Different Parts of Notoginseng {#sec3.3}
-------------------------------------------------------

Untargeted metabolomics has the ability to profile diverse classes of metabolites and thereby has been widely used for comparing the overall metabolic composition between samples.^[@ref44]^ Among the techniques used for untargeted metabolomics, UPLC-Q-TOF MS has been especially widely utilized for profiling metabolites due to its superiority in high-resolution mass, precision, and sensitivity. In the current study, \>15000 ions were achieved in the UPLC-Q-TOF MS data of notoginseng. Analysis results of these ions were exported for subsequent multivariate analysis by using SIMCA 13.0. As shown in Figure [4](#fig4){ref-type="fig"}A, separation of rhizome, fibrous root, and main/branch root can be observed in the PLS-DA plots. *Q*^2^, the parameter that estimates how well the model predicts *Y*, was calculated to be 63.8% (five significant components, *R*^2^*Y* = 91.2%) for this PLS-DA model, suggesting the good predictive capacity of the model. To minimize any effects of nonrelevant metabolite variability, OPLS-DA analyses were also carried out to identify the differences between groups (Figure [4](#fig4){ref-type="fig"}B). Consistent with the results obtained from quantitative analysis, branch root and main root were very close in the OPLS-DA plot, indicating high similarity of the two parts. In a loading plot, the ions farthest away from the main cluster of ions possess the higher VIP value and play more important roles in the differentiation. As shown in Figure [4](#fig4){ref-type="fig"}C, a number of ions were distant from the main cluster and were identified as the marker ions. These marker ions were identified according to the accurate mass, retention time, and targeted MS/MS data. Figure [5](#fig5){ref-type="fig"} represents examples for the identification of potential markers by MS/MS data. A list of the identified marker ions is shown in Table [2](#tbl2){ref-type="other"}, which included both major and minor constituents in notoginseng. This result suggested ginsenosides Rf, Rg~1~, Re, Rg~2~, Rh~1~, Rb~1~, Rb~2~, Rd, and Rg~3~ and notoginsenosides A, Fa, Fc, I, K, R~1~, R~2~, R~4~, and Rw~1~, as well as malonyl-ginsenosides Rb~1~ and Rd were the major potential marker compounds responsible for differentiation of rhizome, main root, branch root, and fibrous root of *P. notoginseng*.

![PLS-DA scores plot (A), OPLS-DA scores plot (B), and loading plot (C) of UPLC-Q-TOF MS data of rhizome (1), main root (2), branch root (3), and fibrous root (4) of *P. notoginseng*.](jf-2014-02214x_0004){#fig4}

![Targeted MS/MS of representative markers (A, malonyl ginsenoside Rb~1~; B, notginsenoside Rw~1~) contributing to the differentiation of different parts of notoginseng. Nomenclature of the fragments was assigned according to a systematic nomenclature for carbohydrate fragmentations.^[@ref46]^](jf-2014-02214x_0005){#fig5}

The relative contents of the first 20 potential marker compounds in each part of notoginseng were then compared on the basis of their peak areas. As shown in Figure [6](#fig6){ref-type="fig"}, notoginsenosides Fc and Rw~1~, malonyl-ginsenoside Rd, and ginsenoside Rb~2~ were found to present in rhizome at significantly higher content than in other parts. It is worth pointing out that both quantitative and multivariate analyses showed that the content of ginsenoside Rb~2~ was much higher in rhizome than in other parts of notoginseng. This implied the potential marker compounds identified from the multivariate analysis were instructive.

![Relative contents of 20 marker compounds in different parts of notoginseng. To compare the level of individual markers between different parts, the content of each marker compound was normalized as a relative content, which was calculated by using the following equation: relative content = content in individual part/sum of the contents in four parts × 100%.](jf-2014-02214x_0006){#fig6}

In the current study, quantitative comparison by using a validated UPLC-Q-TOF MS method and metabolite profiling approach was combinatively employed for evaluating the similarities and differences among rhizome, main root, branch root, and fibrous root of *P. notoginseng*. Both quantitative analysis and metabolite profiling study suggested that rhizome was significantly different from the other parts. It contained the highest contents of individual saponin and total saponins, clearly suggesting the suitability of this part as the raw material for the manufacture of ginsenoside-based products. The chemical compositions of the main root and branch root are quite similar and thereby can be utilized equivalently. The fibrous root also showed a clear separation from the other parts and contained the lowest content of saponins. The multivariate study suggested that notoginsenosides Fc and Rw~1~, malonyl-ginsenoside Rd, and ginsenoside Rb~2~ could be potential chemical markers for discrimination of different parts of notoginseng. Because processing (e.g., steaming) and transformation in the gastrointestinal tract would further introduce chemical diversity of saponins,^[@ref32],[@ref45]^ chemical differences among individual parts of notoginseng might be amplified or become more complicated after processing or oral consumption. Overall, our work represents the first comprehensive study dealing with four parts of notoginseng by using an approach integrating quantitative and qualitative comparison. The result is of importance for the appraisal of the chemical characteristics of different parts of notoginseng and provides chemical evidence for the rational application of each part of notoginseng.

Table S1. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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